Literature DB >> 27262005

Anxiety Disorders in Primary Care.

Danielle H Metzler1, David Mahoney2, John R Freedy3.   

Abstract

Investigation for a possible anxiety disorder should be considered in patients with multiple or persistent anxiety symptoms or multiple somatic complaints without a clear somatic etiology. The ideal treatment for anxiety disorders is a combination of pharmacologic and behavioral strategies. As primary care health care evolves, it is expected that the management of mental health disorders (including anxiety disorders) will largely occur in the context of collaborative care models in which patients and primary care clinicians are assisted by trained case managers who help facilitate a more comprehensive, holistic treatment plan between primary care and mental health providers.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety disorders; Collaborative care; Generalized anxiety disorder; Panic disorder; Pharmacologic treatment; Primary care; Social anxiety disorder

Mesh:

Substances:

Year:  2016        PMID: 27262005     DOI: 10.1016/j.pop.2016.02.002

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  3 in total

1.  Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine.

Authors:  Millie Rincón-Cortés; Kimberly G Gagnon; Hannah K Dollish; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-06-18       Impact factor: 7.853

2.  Effectiveness of a web-based decision aid for patients with generalised anxiety disorder: a protocol for a randomised controlled trial.

Authors:  Lilisbeth Perestelo-Pérez; Amado Rivero-Santana; Vanesa Ramos-García; Yolanda Álvarez-Pérez; Andrea Duarte-Díaz; Alezandra Torres-Castaño; Maria Del Mar Trujillo-Martín; Tasmania Del Pino-Sedeño; Ana Isabel González-González; Pedro Serrano-Aguilar
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

3.  Patient characteristics and changes in anxiety symptoms in patients with panic disorder: Post-hoc analysis of the PARADIES cluster randomised trial.

Authors:  Tobias Dreischulte; Karoline Lukaschek; Marietta Rottenkolber; Jana Werle; Thomas S Hiller; Jörg Breitbart; Ulrike Schumacher; Christian Brettschneider; Jürgen Margraf; Jochen Gensichen
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.